Evidence map›Paper›PMID 18931703›Full record

ArticleOncogene2009

Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.

E S Clark, B Brown, A S Whigham, A Kochaishvili, W G Yarbrough, A M Weaver

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Markers of Cancer Cell Invasion: Are They Good Enough?Journal of clinical medicine · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tks adaptor proteins at a glance.Journal of cell science · 2018
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

E S ClarkDepartment of Cancer Biology, Vanderbilt University, Nashville, TN 37232-6840, USA.
B Brown
A S Whigham
A Kochaishvili
W G Yarbrough
A M Weaver
Vanderbilt University · US

Funding

Cortactin function in lamellipodial protrusionR01GM075126 · NIGMS · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2007 to 2011
$1.4M
Cortactin in HNSSC tumor progressionR21DE018244 · NIDCR · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2007 to 2008
$420k
NIDCR NIH HHS 1R21 DE018244NIDCR NIH HHS R21 DE018244NIGMS NIH HHS R01 GM075126
6 · The paper itself

Abstract

11q13 amplification is a late-stage event in several cancers that is often associated with poor prognosis. Among 11q13-amplified genes, the actin assembly protein cortactin/CTTN is considered a likely candidate for direct involvement in tumor progression because of its cell motility-enhancing functions. We modulated cortactin expression in head and neck squamous cell carcinoma (HNSCC) cell lines. Cortactin expression levels directly correlated with tumor size, vascularization and cell proliferation in an orthotopic HNSCC in vivo model. In contrast, under normal in vitro culture conditions, cortactin expression levels had no effect on cell proliferation. However, cell lines in which cortactin expression was reduced by knockdown (KD) grew poorly in vitro under harsh conditions of growth factor deprivation, anchorage independence and space constraint. In contrast, overexpression of cortactin enhanced in vitro growth under the same harsh conditions. Surprisingly, defects in growth factor-independent proliferation of cortactin-KD cells were rescued by coculture with cortactin-expressing cells. As the cocultured cells are separated by permeable filters, cortactin-expressing cells must secrete growth-supporting autocrine factors to rescue the cortactin-KD cells. Overall, cortactin expression modulates multiple cellular traits that may allow survival in a tumor environment, suggesting that the frequent overexpression of cortactin in tumors is not an epiphenomenon but rather promotes tumor aggressiveness.

Indexed as

AnimalsApoptosisAutocrine CommunicationCarcinoma, Squamous CellCell ProliferationChromosomes, Human, Pair 11Coculture TechniquesCortactinGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansMiceMice, NudeNeoplasm InvasivenessNerve Growth FactorsRatsCortactinNerve Growth FactorsRNA, Small Interfering

Identifiers

PMID18931703
PMCPMC2709457
OpenAlexW2018702961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.